Skip to content

MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: 20-F/A filed 2023-07-03

What MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. reported in its annual report amendment (foreign private issuer) filed 2023-07-03 (fiscal FY 2022): 52 published measures, 135 facts as tagged in accession 0001213900-23-054095.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
20-F/A (annual report amendment (foreign private issuer))
Filed
2023-07-03
Fiscal period
fiscal FY 2022
Accession
0001213900-23-054095 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-12-31163,577,579USD
At 2021-12-31136,857,381USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-12-3124,898,499USD
At 2021-12-3129,088,779USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-12-31138,122,937USD
At 2021-12-31107,768,602USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-12-3126,736,700USD
At 2021-12-318,149,276USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-01-01 to 2022-12-316,242,969USD365
2021-01-01 to 2021-12-3120,949,579USD365
2020-01-01 to 2020-12-3119,045,255USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-9,163,038USD365
2021-01-01 to 2021-12-31-54,663USD365
2020-01-01 to 2020-12-315,325,996USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-12-312,698,729USD365
2021-01-01 to 2021-12-31850,231USD365
2020-01-01 to 2020-12-313,808,259USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-01-01 to 2022-12-31103,346,341USD365
2021-01-01 to 2021-12-31104,037,710USD365
2020-01-01 to 2020-12-3189,061,010USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-12-3137,245,500USD365
2021-01-01 to 2021-12-311,860,234USD365
2020-01-01 to 2020-12-311,706,750USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-8,620,292USD365
2021-01-01 to 2021-12-31-833,817USD365
2020-01-01 to 2020-12-31-16,094,404USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-12-3183,330,239USD
At 2021-12-3177,574,663USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-01-01 to 2022-12-3123,411,068shares365
2021-01-01 to 2021-12-3120,000,000shares365
2020-01-01 to 2020-12-3120,000,000shares366

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-01-01 to 2022-12-3123,411,068shares365
2021-01-01 to 2021-12-3120,000,000shares365
2020-01-01 to 2020-12-3120,000,000shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-01-01 to 2022-12-310.27USD/shares365
2021-01-01 to 2021-12-311.05USD/shares365
2020-01-01 to 2020-12-310.95USD/shares366

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-01-01 to 2022-12-310.27USD/shares365
2021-01-01 to 2021-12-311.05USD/shares365
2020-01-01 to 2020-12-310.95USD/shares366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2022-01-01 to 2022-12-314,713,543USD365
2021-01-01 to 2021-12-315,278,462USD365
2020-01-01 to 2020-12-314,688,321USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-12-318,758,047USD
At 2021-12-317,477,744USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-12-3110,801,962USD365
2021-01-01 to 2021-12-3126,260,954USD365
2020-01-01 to 2020-12-3123,466,226USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-12-31135,319,155USD
At 2021-12-3197,276,350USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-12-3124,173,567USD
At 2021-12-3129,088,779USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-12-3116,096,165USD
At 2021-12-3120,981,041USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-12-31497,600USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-12-3168,945,792USD
At 2021-12-3167,101,297USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-01-01 to 2022-12-3127,296,515USD365
2021-01-01 to 2021-12-3113,544,287USD365
2020-01-01 to 2020-12-3113,693,961USD366

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-12-311,122,038USD
At 2021-12-311,251,393USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-01-01 to 2022-12-3138,098,477USD365
2021-01-01 to 2021-12-3139,805,241USD365
2020-01-01 to 2020-12-3137,160,187USD366

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-01-01 to 2022-12-3165,247,864USD365
2021-01-01 to 2021-12-3164,232,469USD365
2020-01-01 to 2020-12-3151,900,823USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-01-01 to 2022-12-312,962,904USD365
2021-01-01 to 2021-12-312,725,014USD365
2020-01-01 to 2020-12-312,492,059USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-12-3123,940,000shares
At 2021-12-3120,000,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-12-3126,736,700USD
At 2021-12-318,149,276USD
At 2020-12-317,187,334USD
At 2019-12-3116,030,855USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-12-3142,967,006USD
At 2021-12-319,716,484USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-12-31-3,852,138USD
At 2021-12-315,288,988USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2022-12-31138,679,080USD
At 2021-12-31107,768,602USD
At 2020-12-3184,735,780USD
At 2019-12-3159,658,320USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-12-3112,535,348USD
At 2021-12-3114,063,107USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-12-313,777,301USD
At 2021-12-316,585,363USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-12-31497,600USD
At 2021-12-31562,001USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-12-3112,333,122USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-12-3116,428,779USD
At 2021-12-311,394,539USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-01-01 to 2022-12-3110,891,247USD365
2021-01-01 to 2021-12-3126,228,041USD365
2020-01-01 to 2020-12-3123,733,576USD366

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-01-01 to 2022-12-316,177,704USD365
2021-01-01 to 2021-12-3120,949,579USD365
2020-01-01 to 2020-12-3119,045,255USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-2,898,157USD365
2021-01-01 to 2021-12-3123,032,822USD365
2020-01-01 to 2020-12-3123,805,228USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-01-01 to 2022-12-3112,468,551USD365
2021-01-01 to 2021-12-314,361,472USD365
2020-01-01 to 2020-12-314,577,570USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-01-01 to 2022-12-31541,265USD365
2021-01-01 to 2021-12-31595,522USD365
2020-01-01 to 2020-12-31497,238USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-01-01 to 2022-12-31541,265USD365
2021-01-01 to 2021-12-31595,522USD365
2020-01-01 to 2020-12-31497,238USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-01-01 to 2022-12-3122,196USD365
2021-01-01 to 2021-12-3126,951USD365
2020-01-01 to 2020-12-3126,195USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-89,285USD365
2021-01-01 to 2021-12-3132,913USD365
2020-01-01 to 2020-12-31-267,350USD366

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2022-01-01 to 2022-12-314,713,543USD365
2021-01-01 to 2021-12-315,278,462USD365
2020-01-01 to 2020-12-314,688,321USD366

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-12-31194,667USD365
2021-01-01 to 2021-12-31180,744USD365
2020-01-01 to 2020-12-31137,160USD366

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-01-01 to 2022-12-31690,824USD365
2021-01-01 to 2021-12-311,521,767USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-12-317,121,889USD365
2021-01-01 to 2021-12-3120,065,904USD365
2020-01-01 to 2020-12-3113,644,830USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-35,027USD365
2021-01-01 to 2021-12-31-105,121USD365
2020-01-01 to 2020-12-31219,787USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-3,371,275USD365
2021-01-01 to 2021-12-314,908,971USD365
2020-01-01 to 2020-12-315,341,710USD366

Inspect the source

Entity
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. / CIK 0001835615
Captured
2026-09-21T17:36:44.502Z
SEC response SHA-256
0672338a0f4b13b17d54dc76b33fac931920b6061cb0c472c5290b045a207804

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001835615.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))